MEDP | Medpace Holdings, Inc. | 396,65 | -0,60 | -0,15% | 158.427 |
EXEL | Exelixis, Inc. | 21,02 | -0,04 | -0,19% | 1.740.111 |
INCY | Incyte Corporation | 57,40 | 0,21 | +0,37% | 1.728.205 |
ALNY | Alnylam Pharmaceuticals, Inc. | 149,62 | -0,62 | -0,41% | 437.910 |
REGN | Regeneron Pharmaceuticals, Inc. | 993,95 | 6,68 | +0,68% | 326.906 |
CRL | Charles River Laboratories International, Inc. | 221,48 | -1,58 | -0,71% | 360.608 |
CYTK | Cytokinetics, Incorporated | 60,14 | -0,46 | -0,76% | 886.259 |
NBIX | Neurocrine Biosciences, Inc. | 140,55 | -1,10 | -0,78% | 502.982 |
BBIO | BridgeBio Pharma, Inc. | 29,28 | -0,24 | -0,81% | 2.110.060 |
ILMN | Illumina, Inc. | 107,61 | -0,92 | -0,85% | 1.611.226 |
ROIV | Roivant Sciences Ltd. | 11,23 | -0,14 | -1,23% | 2.298.766 |
SRPT | Sarepta Therapeutics, Inc. | 129,12 | -1,71 | -1,31% | 701.608 |
APLS | Apellis Pharmaceuticals, Inc. | 42,56 | -0,66 | -1,53% | 738.187 |
BIIB | Biogen Inc. | 227,69 | -3,89 | -1,68% | 761.211 |
MRNA | Moderna, Inc. | 143,69 | 2,68 | +1,90% | 3.291.130 |
ITCI | Intra-Cellular Therapies, Inc. | 67,00 | 1,68 | +2,57% | 941.795 |
PCVX | Vaxcyte, Inc. | 73,65 | -2,28 | -3,00% | 439.544 |
EXAS | Exact Sciences Corporation | 53,52 | 2,52 | +4,94% | 3.555.177 |